Psomagen (XKRX:950200) Other Stockholders Equity : ₩694 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Psomagen Other Stockholders Equity?

Psomagen's Other Stockholders Equity for the quarter that ended in Mar. 2024 was ₩694 Mil.

Psomagen's quarterly Other Stockholders Equity increased from Sep. 2023 (₩509 Mil) to Dec. 2023 (₩681 Mil) and increased from Dec. 2023 (₩681 Mil) to Mar. 2024 (₩694 Mil).

Psomagen's annual Other Stockholders Equity declined from Dec. 2021 (₩682 Mil) to Dec. 2022 (₩645 Mil) but then increased from Dec. 2022 (₩645 Mil) to Dec. 2023 (₩681 Mil).

Psomagen Other Stockholders Equity Historical Data

The historical data trend for Psomagen's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Psomagen Other Stockholders Equity Chart

Psomagen Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Stockholders Equity

Get a 7-Day Free Trial

381.38

589.84

682.21

644.56

680.96

Psomagen Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Stockholders Equity	Get a 7-Day Free Trial														598.76	464.31	508.62	680.96	693.84

Psomagen Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Psomagen Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Psomagen's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Psomagen (XKRX:950200) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Psomagen Inc (XKRX:950200) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

1330 Piccard Drive, Suite 103, Rockville, MD, USA, 20850

Website

https://www.psomagen.com

Psomagen Inc, formerly Macrogen Corp provides total genomic solutions for both clinical and research purposes. It is mainly focused on end-to-end sequencing services. The company also offers services such as personal DNA tests, clinical sequencing, research sequencing, and others.

Psomagen (XKRX:950200) Headlines

No Headlines